Rick Pauls | President & Chief Executive Officer |
Scott Kellen | Chief Financial Officer |
Harry Alcorn | Chief Medical Officer |
Alexander Nowak | Craig-Hallum Capital Group |
Etzer Darout | Guggenheim Partners |
Francois Brisebois | Oppenheimer & Co. Inc. |
Thomas Flaten | Lake Street Capital Markets, LLC |
Elemer Piros | ROTH Capital Partners |
Jason McCarthy | Maxim Group, LLC |
Good morning, ladies and gentlemen, and welcome to the DiaMedica Therapeutics First Quarter 2021 Conference Call. An audio recording of the webcast will be available shortly after the call today on DiaMedica's website at www.diamedica.com in the Investor Relations section.
Before the company proceeds with its remarks, please note that the company will be making forward-looking statements on today's call. These statements are subject to risk and uncertainties that could cause actual results to differ materially from those projected in these statements. More information, including factors that could cause actual results to differ from projected results appears in the section entitled, Cautionary notes regarding forward looking statements, in the company's press release issued yesterday and under the heading, Risk Factors, in DiaMedica's most recent Annual Report on Form 10-K.